General information
There are approximately 800 new cases of Malignant Lymphomas (ML) in Norway per year (incidence 11/100 000) with an increase of close to 18% during the last ten years. The malignancy consists of Hodgkin disease with approximately 80 new cases and non-Hodgkin Lymphoma with more than 700 cases yearly. For most cases the etiology is unknown, but bacteriae and viruses have been shown to be involved in the pathogenesis for some entities.
The Hospital had up till 1980 a National responsibility for the diagnosis and treatment of Hodgkin disease. Today, the Hospital is the Regional Centre for close to 50% of the Norwegian population with ML.
ML are in principle chemo- and radiosensitive diseases. The course of the disease and response to therapy varies, however, both between subentities of ML and between patients with the same entity. The treatment depends on a correct histopathological diagnosis. During the later years molecular diagnostic techniques are being used to an increasing extent.
The Hospital had up till 1980 a National responsibility for the diagnosis and treatment of Hodgkin disease. Today, the Hospital is the Regional Centre for close to 50% of the Norwegian population with ML.
ML are in principle chemo- and radiosensitive diseases. The course of the disease and response to therapy varies, however, both between subentities of ML and between patients with the same entity. The treatment depends on a correct histopathological diagnosis. During the later years molecular diagnostic techniques are being used to an increasing extent.
Print this page [1091 visits]
